LMAT Lemaitre Vascular Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LMAT

Price (delayed)

$54.36

Market cap

$1.21B

P/E Ratio

47.68

Dividend/share

$0.55

EPS

$1.14

Enterprise value

$1.21B

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, ...

Highlights
LMAT's net income is up by 22% since the previous quarter and by 13% year-on-year
The EPS has grown by 21% from the previous quarter and by 12% YoY
The P/E is 24% more than the 5-year quarterly average of 39.0 but 10% less than the last 4 quarters average of 53.7
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.lemaitre.com/
Peers: ANGO EW BSX BAX

Key stats

What are the main financial stats of LMAT
Market
Shares outstanding
22.26M
Market cap
$1.21B
Enterprise value
$1.21B
Valuations
Price to earnings (P/E)
47.68
Price to book (P/B)
4.24
Price to sales (P/S)
6.82
EV/EBIT
37.41
EV/EBITDA
29.04
EV/Sales
6.82
Earnings
Revenue
$177.17M
EBIT
$32.28M
EBITDA
$41.58M
Free cash flow
$19.81M
Per share
EPS
$1.14
Free cash flow per share
$0.89
Book value per share
$12.81
Revenue per share
$7.98
TBVPS
$9.75
Balance sheet
Total assets
$326.47M
Total liabilities
$42.64M
Debt
$16.81M
Equity
$283.83M
Working capital
$148.64M
Liquidity
Debt to equity
0.06
Current ratio
6.75
Quick ratio
4.51
Net debt/EBITDA
-0.06
Margins
EBITDA margin
23.5%
Gross margin
64.4%
Net margin
14.2%
Operating margin
17.2%
Efficiency
Return on assets
8%
Return on equity
9.3%
Return on invested capital
18.4%
Return on capital employed
10.7%
Return on sales
18.2%
Dividend
Dividend yield
1%
DPS
$0.55
Payout ratio
47.8%

LMAT stock price

How has the Lemaitre Vascular stock price performed over time
Intraday
-1.31%
1 week
-4.63%
1 month
-7.38%
1 year
5.76%
YTD
18.12%
QTD
-19.2%

Financial performance

How have Lemaitre Vascular's revenue and profit performed over time
Revenue
$177.17M
Gross profit
$114.09M
Operating income
$30.44M
Net income
$25.22M
Gross margin
64.4%
Net margin
14.2%
LMAT's net income is up by 22% since the previous quarter and by 13% year-on-year
The company's net margin rose by 16% QoQ and by 2.2% YoY
The operating income has grown by 14% from the previous quarter but it has contracted by 2.1% YoY
The company's operating margin fell by 12% YoY but it rose by 9% QoQ

Growth

What is Lemaitre Vascular's growth rate over time

Valuation

What is Lemaitre Vascular stock price valuation
LMAT P/E details
P/E
47.68
P/B
4.24
P/S
6.82
EV/EBIT
37.41
EV/EBITDA
29.04
EV/Sales
6.82
The P/E is 24% more than the 5-year quarterly average of 39.0 but 10% less than the last 4 quarters average of 53.7
The EPS has grown by 21% from the previous quarter and by 12% YoY
The equity has grown by 10% YoY and by 3.5% from the previous quarter
LMAT's price to book (P/B) is 4.4% lower than its 5-year quarterly average of 4.5 and 2.3% lower than its last 4 quarters average of 4.4
Lemaitre Vascular's revenue has increased by 11% YoY and by 4.7% from the previous quarter
The P/S is 10% above the 5-year quarterly average of 6.3 but 2.7% below the last 4 quarters average of 7.1

Efficiency

How efficient is Lemaitre Vascular business performance
Lemaitre Vascular's return on assets has increased by 19% QoQ and by 5% YoY
The ROE has grown by 19% from the previous quarter and by 7% YoY
LMAT's ROIC is up by 12% since the previous quarter but it is down by 9% year-on-year
The ROS has grown by 12% from the previous quarter but it has contracted by 6% YoY

Dividends

What is LMAT's dividend history
Dividend details
DPS
$0.55
Dividend yield
1%
Payout ratio
47.8%
Recent dividends

Financial health

How did Lemaitre Vascular financials performed over time
The company's total assets rose by 9% YoY and by 3.7% QoQ
LMAT's quick ratio is up by 9% YoY
The company's debt is 94% lower than its equity
Lemaitre Vascular's debt to equity has decreased by 14% YoY
The equity has grown by 10% YoY and by 3.5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.